{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:04:49Z","timestamp":1766901889166,"version":"3.48.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11051-8","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:55:54Z","timestamp":1758549354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quercetin and hematological cancers: where are we and where are we going?"],"prefix":"10.1007","volume":"52","author":[{"given":"Reza","family":"Arefnezhad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Alishahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohadese","family":"Hematian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aryan","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Khalilian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzad Nasrpour","family":"Tahouneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Foroozand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Rezaei-Tazangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"issue":"4","key":"11051_CR1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/cbin.11991","volume":"47","author":"R ArefNezhad","year":"2023","unstructured":"ArefNezhad R, Rezaei-Tazangi F, Roghani\u2010Shahraki H, Goleij P, Zare N, Motedayyen H, Aghazadeh E (2023) Human umbilical cord mesenchymal stem cells: heralding an effective treatment against esophageal cancer? Cell Biol Int 47(4):714\u2013719","journal-title":"Cell Biol Int"},{"key":"11051_CR2","doi-asserted-by":"crossref","first-page":"1203892","DOI":"10.3389\/fcimb.2023.1203892","volume":"13","author":"AM Khateb","year":"2023","unstructured":"Khateb AM, Alkhaibari SA (2023) Cross-sectional investigation of mycological diagnosis challenges in Saudi Arabia. Front Cell Infect Microbiol 13:1203892","journal-title":"Front Cell Infect Microbiol"},{"key":"11051_CR3","doi-asserted-by":"crossref","unstructured":"Amin SA, Khatun S, Gayen S, Das S, Jha T (2023) Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)? Eur J Med Chem. :115594","DOI":"10.1016\/j.ejmech.2023.115594"},{"issue":"1","key":"11051_CR4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-023-01736-8","volume":"22","author":"A Andrades","year":"2023","unstructured":"Andrades A, Peinado P, Alvarez-Perez JC, Sanjuan-Hidalgo J, Garc\u00eda DJ, Arenas AM et al (2023) SWI\/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities. Mol Cancer 22(1):39","journal-title":"Mol Cancer"},{"key":"11051_CR5","doi-asserted-by":"crossref","first-page":"1103785","DOI":"10.3389\/fbioe.2022.1103785","volume":"10","author":"H Liang","year":"2023","unstructured":"Liang H, Shi R, Wang H, Zhou Y (2023) Advances in the application of Raman spectroscopy in haematological tumours. Front Bioeng Biotechnol 10:1103785","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"11051_CR6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/cells12030433","volume":"12","author":"JC Santos","year":"2023","unstructured":"Santos JC, Profit\u00f3s-Pelej\u00e0 N, S\u00e1nchez-Vinces S, Rou\u00e9 G (2023) RHOA therapeutic targeting in hematological cancers. Cells 12(3):433","journal-title":"Cells"},{"key":"11051_CR7","doi-asserted-by":"crossref","first-page":"1347402","DOI":"10.3389\/fonc.2024.1347402","volume":"14","author":"S Saluja","year":"2024","unstructured":"Saluja S, Bansal I, Bhardwaj R, Beg MS, Palanichamy JK (2024) Inflammation as a driver of hematological malignancies. Front Oncol 14:1347402","journal-title":"Front Oncol"},{"key":"11051_CR8","doi-asserted-by":"crossref","unstructured":"Vecchio L, Etet PFS, Kipanyula MJ, Krampera M, Kamdje AHN (2013) Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: what can be learned from hematologic malignancies? Biochimica et biophysica acta (BBA)-Reviews on cancer. 1836(1):90\u2013104","DOI":"10.1016\/j.bbcan.2013.04.001"},{"key":"11051_CR9","doi-asserted-by":"crossref","first-page":"1426454","DOI":"10.3389\/fmmed.2024.1426454","volume":"4","author":"AH Nwabo Kamdje","year":"2024","unstructured":"Nwabo Kamdje AH, Dongmo Fogang HP, Mimche PN (2024) Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy. Front Mol Med 4:1426454","journal-title":"Front Mol Med"},{"issue":"1","key":"11051_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1158\/1541-7786.MCR-23-0080","volume":"22","author":"N Hussein","year":"2024","unstructured":"Hussein N, Rajasuriar R, Khan AM, Lim YA-L, Gan GG (2024) The role of the gut Microbiome in hematological cancers. Mol Cancer Res 22(1):7\u201320","journal-title":"Mol Cancer Res"},{"key":"11051_CR11","doi-asserted-by":"crossref","unstructured":"Bilgihan MT, Ciftciler R (2023) The effect of obesity and body mass index on hematologic malignancies. Metabolic Syndrome and Related Disorders","DOI":"10.1089\/met.2023.0048"},{"key":"11051_CR12","doi-asserted-by":"crossref","unstructured":"Alehashemi S, Ward MM (eds) (2022) Risk of hematologic malignancies in elderly patients with ankylosing spondylitis: a cohort study and systematic review. Mayo Clinic Proceedings; : Elsevier","DOI":"10.1016\/j.mayocp.2022.06.030"},{"issue":"3","key":"11051_CR13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ajh.26445","volume":"97","author":"D Heidenreich","year":"2022","unstructured":"Heidenreich D, Hansen E, Kreil S, Nolte F, Jawhar M, Hecht A et al (2022) The insertion site is the main risk factor for central venous catheter-related complications in patients with hematologic malignancies. Am J Hematol 97(3):303\u2013310","journal-title":"Am J Hematol"},{"issue":"7","key":"11051_CR14","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/MIB.0b013e318281325e","volume":"19","author":"W Afif","year":"2013","unstructured":"Afif W, Sandborn WJ, Faubion WA, Rahman M, Harmsen SW, Zinsmeister AR et al (2013) Risk factors for lymphoma in patients with inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 19(7):1384\u20131389","journal-title":"Inflamm Bowel Dis"},{"key":"11051_CR15","doi-asserted-by":"crossref","unstructured":"Samy L, Bondeelle L, Bergeron A (2023) Pulmonary manifestations of hematological malignancies: focus on pulmonary chronic Graft-Versus-Host disease. Orphan lung diseases: A clinical guide to rare lung disease. Springer, pp 705\u2013714","DOI":"10.1007\/978-3-031-12950-6_40"},{"issue":"10","key":"11051_CR16","first-page":"2448","volume":"105","author":"OA Botrugno","year":"2020","unstructured":"Botrugno OA, Bianchessi S, Zambroni D, Frenquelli M, Belloni D, Bongiovanni L et al (2020) ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies. Haematologica 105(10):2448","journal-title":"Haematologica"},{"issue":"1","key":"11051_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-022-00441-w","volume":"11","author":"S Wang","year":"2023","unstructured":"Wang S, Zhao X, Wu S, Cui D, Xu Z (2023) Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies. Biomark Res 11(1):1\u201320","journal-title":"Biomark Res"},{"key":"11051_CR18","doi-asserted-by":"crossref","first-page":"100167","DOI":"10.1016\/j.crphar.2023.100167","volume":"6","author":"SA Mir","year":"2024","unstructured":"Mir SA, Dar A, Hamid L, Nisar N, Malik JA, Ali T et al (2024) Flavonoids as promising molecules in the cancer therapy: an insight. Curr Res Pharmacol Drug Discovery 6:100167","journal-title":"Curr Res Pharmacol Drug Discovery"},{"key":"11051_CR19","doi-asserted-by":"crossref","unstructured":"Madureira MB, Concato VM, Cruz EMS, Bitencourt de Morais JM, Inoue FSR, Concimo Santos N et al (2023) Naringenin and hesperidin as promising alternatives for prevention and Co-Adjuvant therapy for breast cancer. Antioxid (Basel Switzerland). ;12(3)","DOI":"10.3390\/antiox12030586"},{"issue":"3","key":"11051_CR20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40995-020-00870-y","volume":"44","author":"F Rezaee-Tazangi","year":"2020","unstructured":"Rezaee-Tazangi F, Varaa N, Khorsandi L, Abbaspour M (2020) Effects of silymarin-loaded polylactic-co-glycolic acid nanoparticles on osteoarthritis in rats. Iran J Sci Technol Trans A: Sci 44(3):605\u2013614","journal-title":"Iran J Sci Technol Trans A: Sci"},{"issue":"8","key":"11051_CR21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ddr.21726","volume":"81","author":"QQ Lu","year":"2020","unstructured":"Lu QQ, Chen YM, Liu HR, Yan JY, Cui PW, Zhang QF et al (2020) Nitrogen-containing flavonoid and their analogs with diverse B-ring in acetylcholinesterase and butyrylcholinesterase Inhibition. Drug Dev Res 81(8):1037\u20131047","journal-title":"Drug Dev Res"},{"issue":"23","key":"11051_CR22","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.3390\/molecules29235760","volume":"29","author":"A Intharuksa","year":"2024","unstructured":"Intharuksa A, Kuljarusnont S, Sasaki Y, Tungmunnithum D (2024) Flavonoids and other polyphenols: bioactive molecules from traditional medicine Recipes\/Medicinal plants and their potential for phytopharmaceutical and medical application. Molecules 29(23):5760","journal-title":"Molecules"},{"key":"11051_CR23","doi-asserted-by":"crossref","first-page":"153736","DOI":"10.1016\/j.phymed.2021.153736","volume":"92","author":"H Zou","year":"2021","unstructured":"Zou H, Ye H, Kamaraj R, Zhang T, Zhang J, Pavek P (2021) A review on Pharmacological activities and synergistic effect of Quercetin with small molecule agents. Phytomedicine: Int J Phytotherapy Phytopharmacology 92:153736","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"issue":"9\u201310","key":"11051_CR24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000525494","volume":"107","author":"F Samadi","year":"2022","unstructured":"Samadi F, Kahrizi MS, Heydari F, Arefnezhad R, Roghani-Shahraki H, Mokhtari Ardekani A, Rezaei-Tazangi F (2022) Quercetin and osteoarthritis: A mechanistic review on the present documents. Pharmacology 107(9\u201310):464\u2013471","journal-title":"Pharmacology"},{"key":"11051_CR25","doi-asserted-by":"crossref","first-page":"1310023","DOI":"10.3389\/fphar.2023.1310023","volume":"14","author":"YF Zeng","year":"2023","unstructured":"Zeng YF, Li JY, Wei XY, Ma SQ, Wang QG, Qi Z et al (2023) Preclinical evidence of reno-protective effect of Quercetin on acute kidney injury: a meta-analysis of animal studies. Front Pharmacol 14:1310023","journal-title":"Front Pharmacol"},{"key":"11051_CR26","doi-asserted-by":"crossref","first-page":"102665","DOI":"10.1016\/j.arr.2025.102665","volume":"104","author":"J Pei","year":"2025","unstructured":"Pei J, Kumarasamy RV, Jayaraman S, Kanniappan GV, Long Q, Palanisamy CP (2025) Quercetin-functionalized nanomaterials: innovative therapeutic avenues for alzheimer\u2019s disease management. Ageing Res Rev 104:102665","journal-title":"Ageing Res Rev"},{"issue":"1","key":"11051_CR27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12885-025-13709-9","volume":"25","author":"J Sun","year":"2025","unstructured":"Sun J, Sha M, Zhou J, Huang Y (2025) Quercetin affects apoptosis and autophagy in pediatric acute myeloid leukaemia cells by inhibiting PI3K\/AKT signaling pathway activation through regulation of miR-224-3p\/PTEN axis. BMC Cancer 25(1):318","journal-title":"BMC Cancer"},{"key":"11051_CR28","unstructured":"Tune BXJ, Wu YS, Mac Guad R, Manap ASA, Afzal S, Batumalaie K et al (2024) Preclinical Therapeutic Effects of Quercetin on Gastrointestinal Cancers. Quercetin\u2013Effects on Human Health: InTechOpen; pp. 137\u2009\u2013\u200966"},{"issue":"9","key":"11051_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.31083\/j.ceog5109205","volume":"51","author":"A Biyabani","year":"2024","unstructured":"Biyabani A, Mazidimoradi A, Ghorbani F, Allahqoli L, Salehiniya H (2024) The effect of Quercetin on the prevention and treatment of gynecologic cancer. Clin Exp Obstet Gynecol 51(9):205","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"26","key":"11051_CR30","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.2174\/0109298673266672231121173432","volume":"31","author":"MS Jamshidi-Mouselou","year":"2024","unstructured":"Jamshidi-Mouselou MS, Hashemi A, Jamshidi-Mouselou MS, Farkhondeh T, Pourhanifeh MH, Samarghandian S (2024) Application of Quercetin and its novel formulations in the treatment of malignancies of central nervous system: an updated review of current evidence based on molecular mechanisms. Curr Med Chem 31(26):4180\u20134198","journal-title":"Curr Med Chem"},{"issue":"11","key":"11051_CR31","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3390\/ph16111631","volume":"16","author":"MA Mirza","year":"2023","unstructured":"Mirza MA, Mahmood S, Hilles AR, Ali A, Khan MZ, Zaidi SAA et al (2023) Quercetin as a therapeutic product: evaluation of its Pharmacological action and clinical applications\u2014a review. Pharmaceuticals 16(11):1631","journal-title":"Pharmaceuticals"},{"issue":"1","key":"11051_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12906-025-04782-5","volume":"25","author":"S Tubtimsri","year":"2025","unstructured":"Tubtimsri S, Chuenbarn T, Manmuan S (2025) Quercetin triggers cell apoptosis-associated ROS-mediated cell death and induces S and G2\/M-phase cell cycle arrest in KON oral cancer cells. BMC Complement Med Ther 25(1):34","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"11051_CR33","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/medicina61040656","volume":"61","author":"T Hoinoiu","year":"2025","unstructured":"Hoinoiu T, Dumitrascu V, Pit D, Schipor D-A, Jabri-Tabrizi M, Hoinoiu B et al (2025) Quercetin as a potential therapeutic agent for malignant Melanoma\u2014A review of current evidence and future directions. Medicina 61(4):656","journal-title":"Medicina"},{"key":"11051_CR34","doi-asserted-by":"crossref","first-page":"111847","DOI":"10.1016\/j.biopha.2021.111847","volume":"141","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Shoorei H, Sasi AK, Taheri M, Ayatollahi SA (2021) The impact of the phytotherapeutic agent Quercetin on expression of genes and activity of signaling pathways. Biomed Pharmacother 141:111847","journal-title":"Biomed Pharmacother"},{"key":"11051_CR35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cbi.2019.01.008","volume":"300","author":"D Teekaraman","year":"2019","unstructured":"Teekaraman D, Elayapillai SP, Viswanathan MP, Jagadeesan A (2019) Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line. Chemico-Biol Interact 300:91\u2013100","journal-title":"Chemico-Biol Interact"},{"issue":"8","key":"11051_CR36","doi-asserted-by":"crossref","first-page":"e0160686","DOI":"10.1371\/journal.pone.0160686","volume":"11","author":"AK Maurya","year":"2016","unstructured":"Maurya AK, Vinayak M (2016) PI-103 and Quercetin attenuate PI3K-AKT signaling pathway in T- cell lymphoma exposed to hydrogen peroxide. PLoS ONE 11(8):e0160686","journal-title":"PLoS ONE"},{"issue":"1","key":"11051_CR37","doi-asserted-by":"crossref","first-page":"9242601","DOI":"10.1155\/2020\/9242601","volume":"2020","author":"R Lin","year":"2020","unstructured":"Lin R, Piao M, Song Y, Liu C (2020) Quercetin suppresses AOM\/DSS-induced colon carcinogenesis through its anti\u2010inflammation effects in mice. J Immunol Res 2020(1):9242601","journal-title":"J Immunol Res"},{"key":"11051_CR38","doi-asserted-by":"crossref","unstructured":"Jakobu\u0161i\u0107 Brala C, Karkovi\u0107 Markovi\u0107 A, Kugi\u0107 A, Tori\u0107 J, Barbari\u0107 M (2023) Combination chemotherapy with selected polyphenols in preclinical and clinical Studies-An update overview. Molecules. ;28(9)","DOI":"10.3390\/molecules28093746"},{"issue":"1","key":"11051_CR39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jcb.21977","volume":"106","author":"JH Jeong","year":"2009","unstructured":"Jeong JH, An JY, Kwon YT, Rhee JG, Lee YJ (2009) Effects of low dose quercetin: cancer cell-specific Inhibition of cell cycle progression. J Cell Biochem 106(1):73\u201382","journal-title":"J Cell Biochem"},{"issue":"3","key":"11051_CR40","first-page":"833","volume":"38","author":"R Boly","year":"2011","unstructured":"Boly R, Gras T, Lamkami T, Guissou P, Serteyn D, Kiss R et al (2011) Quercetin inhibits a large panel of kinases implicated in cancer cell biology. Int J Oncol 38(3):833\u2013842","journal-title":"Int J Oncol"},{"issue":"2","key":"11051_CR41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/or.2017.5766","volume":"38","author":"M Hashemzaei","year":"2017","unstructured":"Hashemzaei M, Delarami Far A, Yari A, Heravi RE, Tabrizian K, Taghdisi SM et al (2017) Anticancer and apoptosis\u2013inducing effects of Quercetin in vitro and in vivo. Oncol Rep 38(2):819\u2013828","journal-title":"Oncol Rep"},{"issue":"2","key":"11051_CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MPA.0b013e318264ccae","volume":"42","author":"E Angst","year":"2013","unstructured":"Angst E, Park JL, Moro A, Lu Q-Y, Lu X, Li G et al (2013) The flavonoid Quercetin inhibits pancreatic cancer growth in vitro and in vivo. Pancreas 42(2):223\u2013229","journal-title":"Pancreas"},{"key":"11051_CR43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.intimp.2017.03.029","volume":"47","author":"R Wang","year":"2017","unstructured":"Wang R, Zhang H, Wang Y, Song F, Yuan Y (2017) Inhibitory effects of Quercetin on the progression of liver fibrosis through the regulation of NF-\u043aB\/I\u043aB\u03b1, p38 MAPK, and Bcl-2\/Bax signaling. Int Immunopharmacol 47:126\u2013133","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"11051_CR44","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/pharmaceutics15020712","volume":"15","author":"G Sethi","year":"2023","unstructured":"Sethi G, Rath P, Chauhan A, Ranjan A, Choudhary R, Ramniwas S et al (2023) Apoptotic mechanisms of Quercetin in liver cancer: recent trends and advancements. Pharmaceutics 15(2):712","journal-title":"Pharmaceutics"},{"issue":"12","key":"11051_CR45","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.bbamcr.2013.06.001","volume":"1833","author":"V Nikoletopoulou","year":"2013","unstructured":"Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N (2013) Crosstalk between apoptosis, necrosis and autophagy. Biochim Et Biophys Acta (BBA)-Molecular Cell Res 1833(12):3448\u20133459","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Cell Res"},{"key":"11051_CR46","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s10495-015-1169-2","volume":"20","author":"H Gali-Muhtasib","year":"2015","unstructured":"Gali-Muhtasib H, Hmadi R, Kareh M, Tohme R, Darwiche N (2015) Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis. Apoptosis 20:1531\u20131562","journal-title":"Apoptosis"},{"key":"11051_CR47","doi-asserted-by":"crossref","first-page":"1077531","DOI":"10.3389\/fimmu.2023.1077531","volume":"14","author":"N Lotfi","year":"2023","unstructured":"Lotfi N, Yousefi Z, Golabi M, Khalilian P, Ghezelbash B, Montazeri M et al (2023) The potential anti-cancer effects of Quercetin on blood, prostate and lung cancers: an update. Front Immunol 14:1077531","journal-title":"Front Immunol"},{"key":"11051_CR48","doi-asserted-by":"crossref","unstructured":"Zhuang H, He X, Li H, Chen Y, Wu T, Jiang X et al (2023) MnS nanocapsule mediates mitochondrial membrane permeability transition for tumor Ion-Interference therapy. ACS Nano","DOI":"10.1021\/acsnano.3c03670"},{"issue":"13","key":"11051_CR49","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.3390\/ijms20133177","volume":"20","author":"M Reyes-Farias","year":"2019","unstructured":"Reyes-Farias M, Carrasco-Pozo C (2019) The anti-cancer effect of quercetin: molecular implications in cancer metabolism. Int J Mol Sci 20(13):3177","journal-title":"Int J Mol Sci"},{"key":"11051_CR50","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.2147\/OTT.S136840","volume":"10","author":"D Yu","year":"2017","unstructured":"Yu D, Ye T, Xiang Y, Shi Z, Zhang J, Lou B et al (2017) Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells. Onco Targets Ther 10:4719\u20134729","journal-title":"Onco Targets Ther"},{"key":"11051_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02067-8","volume":"21","author":"P Maleki Dana","year":"2021","unstructured":"Maleki Dana P, Sadoughi F, Asemi Z, Yousefi B (2021) Anti-cancer properties of Quercetin in osteosarcoma. Cancer Cell Int 21:1\u20139","journal-title":"Cancer Cell Int"},{"key":"11051_CR53","doi-asserted-by":"crossref","unstructured":"Arefnezhad R, Amin SS, Mohammdi A, Ahmadi G, Jahandideh A, Goleij P et al (2024) Quercetin and its nanoformulations as promising agents for lung cancer treatment: a focus on molecular mechanisms. J Drug Deliv Sci Technol. :105933","DOI":"10.1016\/j.jddst.2024.105933"},{"issue":"3","key":"11051_CR54","doi-asserted-by":"crossref","first-page":"e70146","DOI":"10.1111\/1541-4337.70146","volume":"24","author":"R Zhao","year":"2025","unstructured":"Zhao R, Hu S, Chen T, Li Y, Chi X, Yu S et al (2025) Innovative delivery strategies for quercetin: A comprehensive review of advances and challenges. Compr Rev Food Sci Food Saf 24(3):e70146","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"11051_CR55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tifs.2021.11.032","volume":"119","author":"K Kandemir","year":"2022","unstructured":"Kandemir K, Tomas M, McClements DJ, Capanoglu E (2022) Recent advances on the improvement of Quercetin bioavailability. Trends Food Sci Technol 119:192\u2013200","journal-title":"Trends Food Sci Technol"},{"issue":"22","key":"11051_CR56","doi-asserted-by":"crossref","first-page":"12091","DOI":"10.3390\/ijms252212091","volume":"25","author":"O-D Fren\u021b","year":"2024","unstructured":"Fren\u021b O-D, Stefan L, Morgovan CM, Duteanu N, Dejeu IL, Marian E et al (2024) A systematic review: Quercetin\u2014Secondary metabolite of the flavonol Class, with multiple health benefits and low bioavailability. Int J Mol Sci 25(22):12091","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11051_CR57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/fft2.50","volume":"1","author":"Y Hai","year":"2020","unstructured":"Hai Y, Zhang Y, Liang Y, Ma X, Qi X, Xiao J et al (2020) Advance on the absorption, metabolism, and efficacy exertion of Quercetin and its important derivatives: absorption, metabolism and function of Quercetin. Food Front 1(4):420\u2013434","journal-title":"Food Front"},{"issue":"1","key":"11051_CR58","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12906-022-03758-z","volume":"22","author":"P Cunningham","year":"2022","unstructured":"Cunningham P, Patton E, VanderVeen BN, Unger C, Aladhami A, Enos RT et al (2022) Sub-chronic oral toxicity screening of Quercetin in mice. BMC Complement Med Ther 22(1):279","journal-title":"BMC Complement Med Ther"},{"issue":"10","key":"11051_CR59","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.lfs.2003.06.044","volume":"74","author":"Y-H Wang","year":"2004","unstructured":"Wang Y-H, Chao P-DL, Hsiu S-L, Wen K-C, Hou Y-C (2004) Lethal quercetin-digoxin interaction in pigs. Life Sci 74(10):1191\u20131197","journal-title":"Life Sci"},{"issue":"1","key":"11051_CR60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.taap.2007.04.004","volume":"222","author":"AW Boots","year":"2007","unstructured":"Boots AW, Li H, Schins RP, Duffin R, Heemskerk JW, Bast A et al (2007) The Quercetin paradox. Toxicol Appl Pharmcol 222(1):89\u201396","journal-title":"Toxicol Appl Pharmcol"},{"issue":"22","key":"11051_CR61","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2217\/nnm-2021-0070","volume":"16","author":"HA Mohammed","year":"2021","unstructured":"Mohammed HA, Sulaiman GM, Anwar SS, Tawfeeq AT, Khan RA, Mohammed SA et al (2021) Quercetin against MCF7 and CAL51 breast cancer cell lines: apoptosis, gene expression and cytotoxicity of nano-quercetin. Nanomedicine 16(22):1937\u20131961","journal-title":"Nanomedicine"},{"issue":"5","key":"11051_CR62","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/1534735414523315","volume":"13","author":"SE Mahoney","year":"2014","unstructured":"Mahoney SE, Davis JM, Murphy EA, McClellan JL, Pena MM (2014) Dietary Quercetin reduces chemotherapy-induced fatigue in mice. Integr Cancer Ther 13(5):417\u2013424","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"11051_CR63","doi-asserted-by":"crossref","first-page":"1700447","DOI":"10.1002\/mnfr.201700447","volume":"62","author":"S Andres","year":"2018","unstructured":"Andres S, Pevny S, Ziegenhagen R, Bakhiya N, Sch\u00e4fer B, Hirsch-Ernst KI et al (2018) Safety aspects of the use of Quercetin as a dietary supplement. Mol Nutr Food Res 62(1):1700447","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"11051_CR64","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1017\/S0007114509359127","volume":"102","author":"S Egert","year":"2009","unstructured":"Egert S, Bosy-Westphal A, Seiberl J, K\u00fcrbitz C, Settler U, Plachta-Danielzik S et al (2009) Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 102(7):1065\u20131074","journal-title":"Br J Nutr"},{"issue":"1","key":"11051_CR65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/biom15010151","volume":"15","author":"HOA Alharbi","year":"2025","unstructured":"Alharbi HOA, Alshebremi M, Babiker AY, Rahmani AH (2025) The role of Quercetin, a flavonoid in the management of pathogenesis through regulation of oxidative Stress, Inflammation, and biological activities. Biomolecules 15(1):151","journal-title":"Biomolecules"},{"key":"11051_CR66","volume-title":"Unveiling the potential of quercetin: Chemistry, health Benefits, Toxicity, and Cutting-Edge advances","author":"MA Ghareeb","year":"2024","unstructured":"Ghareeb MA, Zayan AZ, Shari FH, Sayed AM (2024) Unveiling the potential of quercetin: Chemistry, health Benefits, Toxicity, and Cutting-Edge advances. IntechOpen, Quercetin-Effects on Human Health"},{"key":"11051_CR67","doi-asserted-by":"crossref","first-page":"689044","DOI":"10.3389\/fimmu.2021.689044","volume":"12","author":"P Shen","year":"2021","unstructured":"Shen P, Lin W, Deng X, Ba X, Han L, Chen Z et al (2021) Potential implications of Quercetin in autoimmune diseases. Front Immunol 12:689044","journal-title":"Front Immunol"},{"key":"11051_CR68","doi-asserted-by":"crossref","unstructured":"Di Pierro F, Iqtadar S, Khan A, Ullah Mumtaz S, Masud Chaudhry M, Bertuccioli A et al (2021) Potential clinical benefits of Quercetin in the early stage of COVID-19: results of a second, pilot, randomized, controlled and open-label clinical trial. Int J Gen Med. :2807\u20132816","DOI":"10.2147\/IJGM.S318949"},{"issue":"3","key":"11051_CR69","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s43450-022-00347-6","volume":"33","author":"K Ding","year":"2023","unstructured":"Ding K, Jia H, Jiang W, Qin Y, Wang Y, Lei M (2023) A double-edged sword: focusing on potential drug-to-drug interactions of Quercetin. Revista Brasileira De Farmacognosia 33(3):502\u2013513","journal-title":"Revista Brasileira De Farmacognosia"},{"issue":"12","key":"11051_CR70","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/ptr.5220","volume":"28","author":"H Rastogi","year":"2014","unstructured":"Rastogi H, Jana S (2014) Evaluation of inhibitory effects of caffeic acid and Quercetin on human liver cytochrome p450 activities. Phytother Res 28(12):1873\u20131878","journal-title":"Phytother Res"},{"issue":"1","key":"11051_CR71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajh.26744","volume":"98","author":"C Radkiewicz","year":"2023","unstructured":"Radkiewicz C, Bruchfeld JB, Weibull CE, Jeppesen ML, Frederiksen H, Lambe M et al (2023) Sex differences in lymphoma incidence and mortality by subtype: A population-based study. Am J Hematol 98(1):23\u201330","journal-title":"Am J Hematol"},{"key":"11051_CR72","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.biocel.2016.09.006","volume":"79","author":"M Granato","year":"2016","unstructured":"Granato M, Rizzello C, Romeo MA, Yadav S, Santarelli R, D\u2019Orazi G et al (2016) Concomitant reduction of c-Myc expression and PI3K\/AKT\/mTOR signaling by Quercetin induces a strong cytotoxic effect against burkitt\u2019s lymphoma. Int J Biochem Cell Biol 79:393\u2013400","journal-title":"Int J Biochem Cell Biol"},{"key":"11051_CR73","unstructured":"Kurosaki T B cells. Activating and Inhibitory Immunoglobulin-like Receptors.159"},{"issue":"2","key":"11051_CR74","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/01635581.2015.990574","volume":"67","author":"AK Maurya","year":"2015","unstructured":"Maurya AK, Vinayak M (2015) Quercetin regresses dalton\u2019s lymphoma growth via suppression of PI3K\/AKT signaling leading to upregulation of p53 and decrease in energy metabolism. Nutr Cancer 67(2):354\u2013363","journal-title":"Nutr Cancer"},{"key":"11051_CR75","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhuang Z, Guo M, Wu K, Yang Q, Min X et al (2023) Ze-Qi Decoction inhibits non-small cell lung cancer growth and metastasis by modulating the PI3K\/Akt\/p53 signaling pathway. J Traditional Complement Med","DOI":"10.1016\/j.jtcme.2023.03.008"},{"issue":"1","key":"11051_CR76","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3324\/haematol.2011.046466","volume":"97","author":"G Jacquemin","year":"2012","unstructured":"Jacquemin G, Granci V, Gallouet AS, Lalaoui N, Morl\u00e9 A, Iessi E et al (2012) Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin\u2019s lymphoma B cells. Haematologica 97(1):38","journal-title":"Haematologica"},{"issue":"11","key":"11051_CR77","first-page":"4629","volume":"29","author":"T Kawahara","year":"2009","unstructured":"Kawahara T, Kawaguchi-Ihara N, Okuhashi Y, Itoh M, Nara N, Tohda S (2009) Cyclopamine and Quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res 29(11):4629\u20134632","journal-title":"Anticancer Res"},{"issue":"6","key":"11051_CR78","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3390\/molecules28062540","volume":"28","author":"MK Sah","year":"2023","unstructured":"Sah MK, Gautam B, Pokhrel KP, Ghani L, Bhattarai A (2023) Quantification of the Quercetin nanoemulsion technique using various parameters. Molecules 28(6):2540","journal-title":"Molecules"},{"key":"11051_CR79","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopha.2017.02.112","volume":"91","author":"B Zhu","year":"2017","unstructured":"Zhu B, Yu L, Yue Q (2017) Co-delivery of vincristine and Quercetin by nanocarriers for lymphoma combination chemotherapy. Biomed Pharmacother 91:287\u2013294","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"11051_CR80","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3324\/haematol.2011.046466","volume":"97","author":"G Jacquemin","year":"2012","unstructured":"Jacquemin G, Granci V, Gallouet AS, Lalaoui N, Morl\u00e9 A, Iessi E et al (2012) Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin\u2019s lymphoma B cells. Haematologica 97(1):38\u201346","journal-title":"Haematologica"},{"issue":"2","key":"11051_CR81","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s12013-014-0064-8","volume":"70","author":"X Li","year":"2014","unstructured":"Li X, Wang X, Zhang M, Li A, Sun Z, Yu Q (2014) Quercetin potentiates the antitumor activity of rituximab in diffuse large B-cell lymphoma by inhibiting STAT3 pathway. Cell Biochem Biophys 70(2):1357\u20131362","journal-title":"Cell Biochem Biophys"},{"key":"11051_CR82","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jnutbio.2016.12.011","volume":"41","author":"M Granato","year":"2017","unstructured":"Granato M, Rizzello C, Gilardini Montani MS, Cuomo L, Vitillo M, Santarelli R et al (2017) Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K\/AKT\/mTOR and STAT3 signaling pathways. J Nutr Biochem 41:124\u2013136","journal-title":"J Nutr Biochem"},{"issue":"3","key":"11051_CR83","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/01635581.2017.1267775","volume":"69","author":"AK Maurya","year":"2017","unstructured":"Maurya AK, Vinayak M (2017) Quercetin attenuates cell survival, inflammation, and angiogenesis via modulation of AKT signaling in murine T-cell lymphoma. Nutr Cancer 69(3):470\u2013480","journal-title":"Nutr Cancer"},{"issue":"20","key":"11051_CR84","doi-asserted-by":"crossref","first-page":"11258","DOI":"10.3390\/ijms222011258","volume":"22","author":"K Fujii","year":"2021","unstructured":"Fujii K, Idogawa M, Suzuki N, Iwatsuki K, Kanekura T (2021) Functional depletion of HSP72 by SiRNA and Quercetin enhances vorinostat-induced apoptosis in an HSP72-overexpressing cutaneous T-cell lymphoma cell line, Hut78. Int J Mol Sci 22(20):11258","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11051_CR85","first-page":"112","volume":"78","author":"A Fil\u2019chenkov","year":"2006","unstructured":"Fil\u2019chenkov A, Zavelevich M, Khranovskaia N, Mykha\u012dlenko V (2006) Apoptosis of human malignant lymphoid NAMALWA cells induced by Resveratrol and Quercetin. Ukrains\u2019 Kyi Biokhimichnyi Zhurnal (1999) 78(4):112\u2013119","journal-title":"Ukrains\u2019 Kyi Biokhimichnyi Zhurnal (1999)"},{"issue":"2","key":"11051_CR86","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/genes11020206","volume":"11","author":"C Salazar","year":"2020","unstructured":"Salazar C, Ya\u00f1ez O, Elorza AA, Cortes N, Garc\u00eda-Beltr\u00e1n O, Tiznado W et al (2020) Biosystem analysis of the hypoxia inducible domain family member 2A: implications in cancer biology. Genes 11(2):206","journal-title":"Genes"},{"key":"11051_CR87","doi-asserted-by":"crossref","unstructured":"Zhan X-Z, Wei T-H, Huang C, Yu H, Chen X-L, Kong X-T et al (2024) Modulating JAK2\/STAT3 signaling by Quercetin in Qiling Baitouweng tang: a potential therapeutic approach for diffuse large B-cell lymphoma. Mol Diversity. :1\u201325","DOI":"10.1007\/s11030-024-10999-2"},{"key":"11051_CR88","unstructured":"Chennamadhavuni A, Lyengar V, Shimanovsky A Continuing Education Activity"},{"issue":"7","key":"11051_CR89","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/tox.22408","volume":"32","author":"JL Chang","year":"2017","unstructured":"Chang JL, Chow JM, Chang JH, Wen YC, Lin YW, Yang SF et al (2017) Quercetin simultaneously induces G(0) \/G(1) -phase arrest and caspase-mediated crosstalk between apoptosis and autophagy in human leukemia HL-60 cells. Environ Toxicol 32(7):1857\u20131868","journal-title":"Environ Toxicol"},{"issue":"1","key":"11051_CR90","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1038\/s41598-018-21516-5","volume":"8","author":"AK Calgarotto","year":"2018","unstructured":"Calgarotto AK, Maso V, Junior GCF, Nowill AE, Filho PL, Vassallo J et al (2018) Antitumor activities of Quercetin and green tea in xenografts of human leukemia HL60 cells. Sci Rep 8(1):3459","journal-title":"Sci Rep"},{"issue":"12","key":"11051_CR91","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1158\/1940-6207.CAPR-13-0383","volume":"7","author":"V Maso","year":"2014","unstructured":"Maso V, Calgarotto AK, Franchi GC Jr., Nowill AE, Filho PL, Vassallo J et al (2014) Multitarget effects of Quercetin in leukemia. Cancer Prev Res (Philadelphia Pa) 7(12):1240\u20131250","journal-title":"Cancer Prev Res (Philadelphia Pa)"},{"issue":"1","key":"11051_CR92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13148-018-0563-3","volume":"10","author":"MC Alvarez","year":"2018","unstructured":"Alvarez MC, Maso V, Torello CO, Ferro KP, Saad STO (2018) The polyphenol Quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes. Clin Epigenetics 10(1):139","journal-title":"Clin Epigenetics"},{"issue":"5","key":"11051_CR93","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1593\/neo.121784","volume":"15","author":"R Piazza","year":"2013","unstructured":"Piazza R, Magistroni V, Mogavero A, Andreoni F, Ambrogio C, Chiarle R et al (2013) Epigenetic Silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2\/SIN3a deacetylating complex. Neoplasia 15(5):511\u2013IN17","journal-title":"Neoplasia"},{"issue":"2","key":"11051_CR94","first-page":"583","volume":"25","author":"W-J Lee","year":"2011","unstructured":"Lee W-J, Chen Y-R, Tseng T-H (2011) Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep 25(2):583\u2013591","journal-title":"Oncol Rep"},{"issue":"1","key":"11051_CR95","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3892\/mmr.2015.4600","volume":"13","author":"X Chen","year":"2016","unstructured":"Chen X, Dong XS, Gao HY, Jiang YF, Jin YL, Chang YY et al (2016) Suppression of HSP27 increases the anti\u2013tumor effects of Quercetin in human leukemia U937 cells. Mol Med Rep 13(1):689\u2013696","journal-title":"Mol Med Rep"},{"key":"11051_CR96","doi-asserted-by":"crossref","first-page":"534171","DOI":"10.3389\/fphar.2020.534171","volume":"11","author":"H Shi","year":"2020","unstructured":"Shi H, Li XY, Chen Y, Zhang X, Wu Y, Wang ZX et al (2020) Quercetin induces apoptosis via downregulation of vascular endothelial growth Factor\/Akt signaling pathway in acute myeloid leukemia cells. Front Pharmacol 11:534171","journal-title":"Front Pharmacol"},{"issue":"2","key":"11051_CR97","first-page":"99","volume":"14","author":"H Khoshamooz","year":"2020","unstructured":"Khoshamooz H, Kaviani S, Atashi A, Hassankiadeh SHM (2020) Combination effect of Notch1 and PI3K\/AKT\/mTOR signaling pathways inhibitors on T-ALL cell lines. Int J Hematology-Oncology Stem Cell Res 14(2):99","journal-title":"Int J Hematology-Oncology Stem Cell Res"},{"issue":"9","key":"11051_CR98","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood-2008-04-150227","volume":"112","author":"FT Liu","year":"2008","unstructured":"Liu FT, Agrawal SG, Movasaghi Z, Wyatt PB, Rehman IU, Gribben JG et al (2008) Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Blood 112(9):3835\u20133846","journal-title":"Blood"},{"issue":"9","key":"11051_CR99","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/1568009622666220516102235","volume":"22","author":"K Sak","year":"2022","unstructured":"Sak K (2022) Dietary flavonoids with catechol moiety inhibit anticancer action of bortezomib: what about the other boronic Acid-based drugs? Curr Cancer Drug Targets 22(9):741\u2013748","journal-title":"Curr Cancer Drug Targets"},{"key":"11051_CR100","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s10876-020-01913-5","volume":"32","author":"S Selvaraj","year":"2021","unstructured":"Selvaraj S, Shanmugasundaram S, Maruthamuthu M, Venkidasamy B, Shanmugasundaram S (2021) Facile synthesis and characterization of quercetin-loaded alginate nanoparticles for enhanced in vitro anticancer effect against human leukemic cancer U937 cells. J Cluster Sci 32:1507\u20131518","journal-title":"J Cluster Sci"},{"issue":"2","key":"11051_CR101","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.canlet.2005.09.013","volume":"240","author":"TJ Lee","year":"2006","unstructured":"Lee TJ, Kim OH, Kim YH, Lim JH, Kim S, Park JW et al (2006) Quercetin arrests G2\/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett 240(2):234\u2013242","journal-title":"Cancer Lett"},{"issue":"7","key":"11051_CR102","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1007\/s11033-012-1621-0","volume":"39","author":"Z Yuan","year":"2012","unstructured":"Yuan Z, Long C, Junming T, Qihuan L, Youshun Z, Chan Z (2012) Quercetin-induced apoptosis of HL-60 cells by reducing PI3K\/Akt. Mol Biol Rep 39(7):7785\u20137793","journal-title":"Mol Biol Rep"},{"issue":"2","key":"11051_CR103","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ptr.2841","volume":"24","author":"CS Yu","year":"2010","unstructured":"Yu CS, Lai KC, Yang JS, Chiang JH, Lu CC, Wu CL et al (2010) Quercetin inhibited murine leukemia WEHI-3 cells in vivo and promoted immune response. Phytotherapy Research: Int J Devoted Pharmacol Toxicol Evaluation Nat Prod Derivatives 24(2):163\u2013168","journal-title":"Phytotherapy Research: Int J Devoted Pharmacol Toxicol Evaluation Nat Prod Derivatives"},{"issue":"1","key":"11051_CR104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/abbs\/gmq107","volume":"43","author":"G Niu","year":"2011","unstructured":"Niu G, Yin S, Xie S, Li Y, Nie D, Ma L et al (2011) Quercetin induces apoptosis by activating caspase-3 and regulating Bcl-2 and cyclooxygenase-2 pathways in human HL-60 cells. Acta Biochim Biophys Sin 43(1):30\u201337","journal-title":"Acta Biochim Biophys Sin"},{"issue":"26","key":"11051_CR105","doi-asserted-by":"crossref","first-page":"42571","DOI":"10.18632\/oncotarget.17246","volume":"8","author":"M Russo","year":"2017","unstructured":"Russo M, Milito A, Spagnuolo C, Carbone V, Ros\u00e9n A, Minasi P et al (2017) CK2 and PI3K are direct molecular targets of Quercetin in chronic lymphocytic leukaemia. Oncotarget 8(26):42571","journal-title":"Oncotarget"},{"issue":"7","key":"11051_CR106","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00204-014-1300-0","volume":"89","author":"WJ Lee","year":"2015","unstructured":"Lee WJ, Hsiao M, Chang JL, Yang SF, Tseng TH, Cheng CW et al (2015) Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft. Arch Toxicol 89(7):1103\u20131117","journal-title":"Arch Toxicol"},{"issue":"3","key":"11051_CR107","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1179\/1607845412Y.0000000042","volume":"18","author":"AA Gokbulut","year":"2013","unstructured":"Gokbulut AA, Apohan E, Baran Y (2013) Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest. Hematology 18(3):144\u2013150","journal-title":"Hematology"},{"issue":"1","key":"11051_CR108","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/01635581.2018.1380208","volume":"70","author":"E Mutlu Altunda\u011f","year":"2018","unstructured":"Mutlu Altunda\u011f E, Y\u0131lmaz AM, Ko\u00e7t\u00fcrk S, Taga Y, Yal\u00e7\u0131n AS (2018) Synergistic induction of apoptosis by Quercetin and Curcumin in chronic myeloid leukemia (K562) cells. Nutr Cancer 70(1):97\u2013108","journal-title":"Nutr Cancer"},{"issue":"23","key":"11051_CR109","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1158\/1078-0432.CCR-10-1565","volume":"16","author":"S Cheng","year":"2010","unstructured":"Cheng S, Gao N, Zhang Z, Chen G, Budhraja A, Ke Z et al (2010) Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax. Clin Cancer Research: Official J Am Association Cancer Res 16(23):5679\u20135691","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"11051_CR110","doi-asserted-by":"crossref","unstructured":"Hassanzadeh A, Hosseinzadeh E, Rezapour S, Vahedi G, Haghnavaz N, Marofi F (2019) Quercetin promotes cell cycle arrest and apoptosis and attenuates the proliferation of human chronic myeloid leukemia cell line-K562 through interaction with HSPs (70 and 90), MAT2A and FOXM1. Anti-Cancer agents in medicinal chemistry (Formerly current medicinal chemistry-Anti-Cancer agents). 19(12):1523\u20131534","DOI":"10.2174\/1871520619666190729150442"},{"issue":"1","key":"11051_CR111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"S Srivastava","year":"2016","unstructured":"Srivastava S, Somasagara RR, Hegde M, Nishana M, Tadi SK, Srivastava M et al (2016) Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis. Sci Rep 6(1):1\u201313","journal-title":"Sci Rep"},{"issue":"9","key":"11051_CR112","first-page":"1244","volume":"54","author":"J Xiao","year":"2022","unstructured":"Xiao J, Zhang B, Yin S, Xie S, Huang K, Wang J et al (2022) Quercetin induces autophagy-associated death in HL-60 cells through CaMKK\u03b2\/AMPK\/mTOR signal pathway: Quercetin induces autophagic cell death in AML. Acta Biochim Biophys Sin 54(9):1244","journal-title":"Acta Biochim Biophys Sin"},{"issue":"1","key":"11051_CR113","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1749-6632.2012.06599.x","volume":"1259","author":"C Spagnuolo","year":"2012","unstructured":"Spagnuolo C, Russo M, Bilotto S, Tedesco I, Laratta B, Russo GL (2012) Dietary polyphenols in cancer prevention: the example of the flavonoid Quercetin in leukemia. Ann N Y Acad Sci 1259(1):95\u2013103","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"11051_CR114","doi-asserted-by":"crossref","first-page":"355","DOI":"10.18632\/oncotarget.27883","volume":"12","author":"YAL Ramos","year":"2021","unstructured":"Ramos YAL, Souza OF, Novo MCT, Guimar\u00e3es CFC, Popi AF (2021) Quercetin shortened survival of radio-resistant B-1 cells in vitro and in vivo by restoring miR15a\/16 expression. Oncotarget 12(4):355","journal-title":"Oncotarget"},{"key":"11051_CR115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4993\/acrt.29.55","volume":"29","author":"M Rahbaran","year":"2021","unstructured":"Rahbaran M, Razeghian E (2021) Anti-leukemic effects of the Quercetin on human leukemia U937 cells mediated by down-regulation of Mcl-1, survivin, and XIAP. Ann Cancer Res Th 29:55\u201361","journal-title":"Ann Cancer Res Th"},{"issue":"2","key":"11051_CR116","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/bjc.2011.229","volume":"105","author":"C Spagnuolo","year":"2011","unstructured":"Spagnuolo C, Cerella C, Russo M, Chateauvieux S, Diederich M, Russo GL (2011) Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. Br J Cancer 105(2):221\u2013230","journal-title":"Br J Cancer"},{"key":"11051_CR117","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4419-7756-4_38","volume":"701","author":"M Zhang","year":"2011","unstructured":"Zhang M, Swarts SG, Yin L, Liu C, Tian Y, Cao Y et al (2011) Antioxidant properties of Quercetin. Adv Exp Med Biol 701:283\u2013289","journal-title":"Adv Exp Med Biol"},{"key":"11051_CR118","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cbi.2018.08.015","volume":"294","author":"V Rubio","year":"2018","unstructured":"Rubio V, Garc\u00eda-P\u00e9rez AI, Herr\u00e1ez A, Diez JC (2018) Different roles of Nrf2 and NFKB in the antioxidant imbalance produced by Esculetin or Quercetin on NB4 leukemia cells. Chem Biol Interact 294:158\u2013166","journal-title":"Chem Biol Interact"},{"issue":"4","key":"11051_CR119","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/01635581.2020.1767167","volume":"73","author":"E Mutlu Altunda\u011f","year":"2021","unstructured":"Mutlu Altunda\u011f E, Y\u0131lmaz AM, Serdar BS, Jannuzzi AT, Ko\u00e7t\u00fcrk S, Yal\u00e7\u0131n AS (2021) Synergistic induction of apoptosis by Quercetin and Curcumin in chronic myeloid leukemia (K562) cells: II. signal transduction pathways involved. Nutr Cancer 73(4):703\u2013712","journal-title":"Nutr Cancer"},{"issue":"10","key":"11051_CR120","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.bcp.2008.02.007","volume":"75","author":"AM Ramos","year":"2008","unstructured":"Ramos AM, Aller P (2008) Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Biochem Pharmacol 75(10):1912\u20131923","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"11051_CR121","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1179\/102453311X13085644680104","volume":"16","author":"CB Avci","year":"2011","unstructured":"Avci CB, Yilmaz S, Dogan ZO, Saydam G, Dodurga Y, Ekiz HA et al (2011) Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells. Hematology 16(5):303\u2013307","journal-title":"Hematology"},{"key":"11051_CR122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0563-3","volume":"10","author":"MC Alvarez","year":"2018","unstructured":"Alvarez MC, Maso V, Torello CO, Ferro KP, Saad STO (2018) The polyphenol Quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes. Clin Epigenetics 10:1\u201311","journal-title":"Clin Epigenetics"},{"issue":"7","key":"11051_CR123","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/tox.22408","volume":"32","author":"JL Chang","year":"2017","unstructured":"Chang JL, Chow JM, Chang JH, Wen YC, Lin YW, Yang SF et al (2017) Quercetin simultaneously induces G0\/G1-phase arrest and caspase\u2010mediated crosstalk between apoptosis and autophagy in human leukemia HL\u201060 cells. Environ Toxicol 32(7):1857\u20131868","journal-title":"Environ Toxicol"},{"issue":"2","key":"11051_CR124","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000486361","volume":"139","author":"BW Baron","year":"2018","unstructured":"Baron BW, Thirman MJ, Giurcanu MC, Baron JM (2018) Quercetin therapy for selected patients with PIM1 kinase-positive chronic lymphocytic leukemia\/small lymphocytic lymphoma: A pilot study. Acta Haematol 139(2):132\u2013139","journal-title":"Acta Haematol"},{"key":"11051_CR125","doi-asserted-by":"crossref","unstructured":"Elbezanti WO, Challagundla KB, Jonnalagadda SC, Budak-Alpdogan T, Pandey MK (2023) Past, Present, and a glance into the future of multiple myeloma treatment. Pharmaceuticals (Basel). ;16(3)","DOI":"10.3390\/ph16030415"},{"key":"11051_CR126","doi-asserted-by":"crossref","unstructured":"NIMISHA K, AMBIKA K, THYKATTIL SJ (2023) PRAVITH N. Multiple myeloma-Modern and ayurvedic perspective-a critical review. Kerala J Ayurveda. ;2(2)","DOI":"10.55718\/kja.155"},{"issue":"11","key":"11051_CR127","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/abbs\/gmab128","volume":"53","author":"H Wang","year":"2021","unstructured":"Wang H, Yu D, Zhang H, Ma R, Wu H, Zhai H et al (2021) Quercetin inhibits the proliferation of multiple myeloma cells by upregulating PTPRR expression. Acta Biochim Biophys Sin 53(11):1505\u20131515","journal-title":"Acta Biochim Biophys Sin"},{"issue":"48","key":"11051_CR128","doi-asserted-by":"crossref","first-page":"18306","DOI":"10.1074\/jbc.RA119.010348","volume":"294","author":"Y Wang","year":"2019","unstructured":"Wang Y, Cao J, Liu W, Zhang J, Wang Z, Zhang Y et al (2019) Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating \u03b2-catenin. J Biol Chem 294(48):18306\u201318323","journal-title":"J Biol Chem"},{"key":"11051_CR129","doi-asserted-by":"crossref","first-page":"1076815","DOI":"10.3389\/fphar.2023.1076815","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Yang X, Wang F, Zhao J, Zhang C, Wu D et al (2023) Mechanism of action of asparagus officinalis extract against multiple myeloma using bioinformatics tools, in Silico and in vitro study. Front Pharmacol 14:1076815","journal-title":"Front Pharmacol"},{"issue":"11","key":"11051_CR130","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3109\/10428194.2013.879128","volume":"55","author":"Y Ma","year":"2014","unstructured":"Ma Y, Jin Z, Huang J, Zhou S, Ye H, Jiang S et al (2014) Quercetin suppresses the proliferation of multiple myeloma cells by down-regulating IQ motif-containing GTPase activating protein 1 expression and extracellular signal-regulated kinase activation. Leuk Lymphoma 55(11):2597\u20132604","journal-title":"Leuk Lymphoma"},{"issue":"29","key":"11051_CR131","doi-asserted-by":"crossref","first-page":"45489","DOI":"10.18632\/oncotarget.9993","volume":"7","author":"D He","year":"2016","unstructured":"He D, Guo X, Zhang E, Zi F, Chen J, Chen Q et al (2016) Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models. Oncotarget 7(29):45489\u201345499","journal-title":"Oncotarget"},{"issue":"8","key":"11051_CR132","first-page":"639","volume":"1","author":"AL Gartel","year":"2002","unstructured":"Gartel AL, Tyner AL (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1(8):639\u2013649","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"11051_CR133","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3724\/abbs.2023014","volume":"55","author":"B Zhang","year":"2023","unstructured":"Zhang B, Li B, Xie Y, Chang S, Xu Z, Hu H et al (2023) A novel alkaloid compound, DCZ0358, exerts significant antitumor activity in bortezomib-resistant multiple myeloma cells through Inhibition of JAK2\/STAT3 pathway: Anti-myeloma activity of a novel alkaloid in drug-resistant cells. Acta Biochim Biophys Sin 55(2):215","journal-title":"Acta Biochim Biophys Sin"},{"issue":"4","key":"11051_CR134","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41417-022-00450-9","volume":"30","author":"L Du","year":"2023","unstructured":"Du L, Liu W, Pichiorri F, Rosen ST (2023) SUMOylation Inhibition enhances multiple myeloma sensitivity to Lenalidomide. Cancer Gene Ther 30(4):567\u2013574","journal-title":"Cancer Gene Ther"},{"key":"11051_CR135","doi-asserted-by":"crossref","unstructured":"J\u00f6hrer K, Galarza P\u00e9rez M, Kircher B, \u00c7i\u00e7ek SS, Flavones (2022) Flavonols, Lignans, and caffeic acid derivatives from dracocephalum Moldavica and their in vitro effects on multiple myeloma and acute myeloid leukemia. Int J Mol Sci. ;23(22)","DOI":"10.3390\/ijms232214219"},{"issue":"10","key":"11051_CR136","first-page":"1934578X1601101","volume":"11","author":"Z Canturk","year":"2016","unstructured":"Canturk Z, Dikmen M, Artagan O, Ozarda MG, Ozturk N (2016) Cytotoxic effects of resveratrol, Rutin and Rosmarinic acid on ARH\u201377 human (multiple myeloma) cell line. Nat Prod Commun 11(10):1934578X1601101007","journal-title":"Nat Prod Commun"},{"issue":"4","key":"11051_CR137","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/biof.53","volume":"35","author":"K Sakao","year":"2009","unstructured":"Sakao K, Fujii M, Hou DX (2009) Acetyl derivate of Quercetin increases the sensitivity of human leukemia cells toward apoptosis. BioFactors 35(4):399\u2013405","journal-title":"BioFactors"},{"issue":"24","key":"11051_CR138","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.3390\/polym14245380","volume":"14","author":"N Stoyanova","year":"2022","unstructured":"Stoyanova N, Spasova M, Manolova N, Rashkov I, Georgieva A, Toshkova R (2022) Quercetin-and rutin-containing electrospun cellulose acetate and polyethylene glycol fibers with antioxidant and anticancer properties. Polymers 14(24):5380","journal-title":"Polymers"},{"issue":"10","key":"11051_CR139","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.3390\/molecules29102408","volume":"29","author":"K Sakao","year":"2024","unstructured":"Sakao K, Hamamoto S, Urakawa D, He Z, Hou D-X (2024) Anticancer activity and molecular mechanisms of acetylated and methylated Quercetin in human breast cancer cells. Molecules 29(10):2408","journal-title":"Molecules"},{"issue":"6","key":"11051_CR140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.leukres.2008.09.032","volume":"33","author":"J-P Lin","year":"2009","unstructured":"Lin J-P, Yang J-S, Lu C-C, Chiang J-H, Wu C-L, Lin J-J et al (2009) Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leuk Res 33(6):823\u2013828","journal-title":"Leuk Res"},{"issue":"8","key":"11051_CR141","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/tox.20662","volume":"27","author":"JP Lin","year":"2012","unstructured":"Lin JP, Yang JS, Lin JJ, Lai KC, Lu HF, Ma CY et al (2012) Rutin inhibits human leukemia tumor growth in a murine xenograft model in vivo. Environ Toxicol 27(8):480\u2013484","journal-title":"Environ Toxicol"},{"issue":"10","key":"11051_CR142","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/carcin\/bgm131","volume":"28","author":"S Rubio","year":"2007","unstructured":"Rubio S, Quintana J, Eiroa JL, Triana J, Est\u00e9vez F (2007) Acetyl derivative of Quercetin 3-methyl ether-induced cell death in human leukemia cells is amplified by the Inhibition of ERK. Carcinogenesis 28(10):2105\u20132113","journal-title":"Carcinogenesis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11051-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:03:19Z","timestamp":1766898199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11051-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":141,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11051"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11051-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"936"}}